London Healthtech Roundtable 2026
London Healthtech Roundtable 2026
The London Healthtech Roundtable returns in 2026, convening the UK and Europe’s leading healthtech investors, founders, scientists, clinicians, and family offices for a high-level discussion on where healthcare innovation is heading next.
The Roundtable delivers a tightly curated programme focused on the full life cycle of healthtech and life sciences innovation, from discovery and clinical validation to regulation, reimbursement, and venture scale-up. Sessions will explore investment strategy, AI in medicine, biotech and digital health convergence, and the realities of building companies in highly regulated markets.
Through expert-led panels, closed-door roundtables, and a showcase of early-stage ventures, the event is designed to connect capital with cutting-edge research and commercially ready companies.
If you are investing in, building, or scaling the next generation of healthcare and life sciences businesses, this is where the ecosystem comes together.
Agenda
From 1:00PM - Event Arrivals
1:30PM - 1:45PM - Keynote: The Resilience of UK Healthtech
1:50PM - 2:05PM - Keynote: Winning Budgets for Health AI
2:10PM - 2:45PM - Panel: Turning an NHS Pilot into Revenue
2:45PM - 3:15PM - Break
3:15PM - 3:50PM - Panel: Scaling Across Borders in Europe (and Beyond)
3:55PM - 4:30PM - Panel: What Clinical Evidence Actually Matters to Investors
4:35PM - 5:25PM - Panel: Where Are VCs Actually Looking in Biotech & Life Sciences?
5:25PM - 5:45PM - Closing Remarks & Emerging Healthtech Showcase
5:45PM - 8:00PM - Free Networking
Learn more: londonvcnetwork.com/healthtech
NOTE: This event is free for "Standard" & "Premium" LVCN Members
Sponsor Spotlight: Crowell & Moring LLP
We’re excited to announce Crowell & Moring as a sponsor for this event.
Crowell & Moring is an international law firm with operations in the United States, Europe, and MENA. The firm’s corporate and emerging companies and venture capital teams regularly represent nascent companies, growth stage enterprises, venture funds, global asset managers, and corporate venture investors in a variety of venture investment transactions and other matters, with a focus on health care and life sciences. Linking core transactional knowledge with deep sector-specific regulatory capabilities, the firm provides sophisticated, commercially focused counsel to health care, biotech, and life sciences companies and investors throughout all phases of the investment cycle.